News Focus
News Focus
icon url

DewDiligence

04/26/11 2:34 PM

#118873 RE: jbog #118861

Merck KGaA’s share price did not have any implicit value for Cladribine, so there was no value to lose on account of the BG-12 data. Rebif (and the other interferons) will continue to do ok.